| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701530 | Journal of Thoracic Oncology | 2017 | 20 Pages |
Abstract
These observations suggest that BAP1Î does regulate DNA damage response and influences drug sensitivity. It might therefore be relevant to investigate whether patients with high expression of BAP1Î may be responsive to PARP/PI3K-mTOR inhibitors.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Rossella PhD, Agata MSc, Manuel Ronner, Walter MD, Rolf MD, Lorenza PhD, Emanuela PhD,